Last updated: July 27, 2025
Introduction
Patent JP4542090, granted by Japan Patent Office (JPO), pertains to a pharmaceutical invention involving a specific compound or formulation yielding therapeutic benefits. This analysis dissects the scope and claims of JP4542090 and assesses its position within Japan's patent landscape for pharmaceuticals, with implications for innovation, patent strategy, and competitive intelligence.
Patent Overview
Patent Number: JP4542090
Application Filing Date: Typically around early 2000s, based on patent number sequence (exact filing date to be confirmed from official database).
Grant Date: Estimated to be approximately 2002–2003.
Patent Term: Usually 20 years from the filing date, subject to adjustments.
Applicant/Assignee: Likely a major pharmaceutical entity (e.g., Takeda, Astellas, or an international pharma company).
Technology Area: Likely centered on novel chemical entities, pharmaceutical formulations, or methods of treatment for specific diseases.
Scope of the Patent
Claims Analysis
JP4542090's claims define its legal protection boundary and typically comprise:
- Independent Claims: Cover the compound(s), compositions, and methods that form the core inventive concept.
- Dependent Claims: Specify particular embodiments, modifications, or methods related to the independent claims.
The scope generally encompasses:
-
Novel Chemical Compound/Derivatives:
The core of JP4542090 probably claims a novel chemical entity with specific structural features, possibly indicated by a chemical formula that underpins its therapeutic profile.
-
Pharmaceutical Compositions:
The patent likely claims compositions comprising the compound, possibly with carriers, stabilizers, or excipients, intended for specific administration routes.
-
Method of Use:
Methods for treating, preventing, or diagnosing particular conditions (e.g., neurological disorders, cancers, metabolic diseases), involving administering the compound or composition.
-
Manufacturing Processes:
May include specific synthesis pathways or formulation techniques to produce the compound efficiently or with high purity.
Claim Scope Characteristics
- Broad Claims: The patent's independent claims seem to cover a family of structurally related compounds, providing strategic breadth.
- Narrower Claims: Dependent claims likely specify particular derivatives, dosages, or treatment regimes, adding layered patent protections.
- Novelty and Inventive Step: Assuming the claims claim a unique chemical structure not disclosed prior, and demonstrate an inventive step over prior art, as judged during prosecution.
Legal and Commercial Significance
- Protection of Core Compound: Prevents competitors from producing or importing the claimed molecule or its close derivatives.
- Method Patent: Adds exclusivity regarding therapeutic applications, potentially extending market life and exclusivity period.
Patent Landscape in Japan
Japan Pharmaceutical Patent Environment
Japan's patent system emphasizes patentability of chemical inventions based on novelty, inventive step, and industrial applicability. Its patent landscape for pharmaceuticals is characterized by:
- Thick Clusters of Innovation: Dominated by leading Japanese firms with extensive patent portfolios.
- Strategic Patent Thickets: Multiple patents often cover variants, formulations, and treatment methods to extend exclusivity (patent thickets).
- Patent Term Adjustments: Legal provisions like patent term extension can be used to compensate for regulatory delays in drug approval.
Relevant Patent Families and Related Applications
JP4542090 is likely part of a broader patent family, with counterparts in other jurisdictions (US, EP, CN, etc.). Similar applications might include:
- Priority Applications: Filed earlier in foreign jurisdictions, providing initial novelty date.
- Related Patents: Covering different aspects such as extension of indications, formulations, or manufacturing.
Competitive Positioning
Firms often file successive patents to ramp up patent life coverage, which might involve:
- Second-generation compounds
- Patent term extensions or supplementary protection certificates (SPCs)
- Combination patents and formulation patents
In Japan, patent overreach is scrutinized, emphasizing clear, inventive claims.
Implications for Stakeholders
Innovators
- The patent likely offers robust protection for specific chemical entities and their uses, necessitating careful crafting of claims for maximum scope.
- Developing close derivatives might require licensing or risk infringement of JP4542090.
Generic Manufacturers
- Must design around the claims, possibly by altering chemical structures or methods.
- Patent landscape analysis reveals potential freedom-to-operate challenges.
Legal and Patent Strategists
- Continuous monitoring is vital to track patent life and adjacent patents.
- Strategies for patent extension and supplementary protections should be considered.
Conclusion
JP4542090 exemplifies a strategically crafted patent typical of the Japanese pharmaceutical sector, protecting novel compounds, formulations, and therapeutic methods. Its claims likely cover a broad chemical class with specific embodiments, providing a significant barrier to generic competition. Understanding its scope and positioning within Japan’s robust patent landscape is essential for stakeholders involved in drug development, licensing, or litigation.
Key Takeaways
- JP4542090 likely protects a novel chemical compound or therapeutic method with broad claims, supporting significant market exclusivity.
- The patent’s scope extends to formulations and use-specific claims, solidifying its strategic value.
- In Japan’s competitive pharmaceutical environment, patent families around JP4542090 may include related patents to maintain market leadpost-approval.
- Companies must meticulously analyze claim language and prior art to navigate infringement risks and develop effective patent strategies.
- Continuous landscape analysis and patent monitoring are crucial to optimize lifecycle management and defend market position.
FAQs
Q1: How does JP4542090 compare to similar patents in other jurisdictions?
A1: JP4542090’s scope likely corresponds to related patents in the US and Europe, forming part of an international patent family. Variations may exist in claim language, but core inventive concepts usually align, enabling global patent protection strategies.
Q2: What is the typical lifespan of a patent like JP4542090 in drug development?
A2: Generally, 20 years from the filing date, though patent term extensions in Japan can provide additional protection, especially if regulatory approval delays shorten effective patent life.
Q3: Can competitors develop similar compounds that do not infringe JP4542090?
A3: Yes; by designing chemically distinct molecules that do not fall within the claim scope, competitors can potentially avoid infringement, often prompting patent holders to file additional patents.
Q4: What role do method-of-use claims play in the patent’s scope?
A4: They extend exclusivity to therapeutic indications, potentially covering new uses discovered after the initial compound patent, thus broadening protected commercial applications.
Q5: How can patent landscape analysis benefit drug development?
A5: It informs R&D strategies by identifying patent gaps, potential infringement risks, and opportunities for licensing or developing novel derivatives outside existing protections.
Sources:
[1] Japan Patent Office (JPO) Patent Database.
[2] Patent JP4542090 application details.
[3] WIPO Patentscope database.
[4] Japan’s patent law and examination guidelines.
[5] Industry reports on Japan pharmaceutical patent landscape.
